Evommune, Inc.
- Country
- ๐บ๐ธUnited States
- Ownership
- Holding
- Established
- 2020-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.evommune.com
Phase 2b Study of EVO756 in Adults With Moderate to Severe Chronic Spontaneous Urticaria (CSU)
- Conditions
- Chronic Spontaneous Urticaria
- Interventions
- Drug: Placebo control
- First Posted Date
- 2025-03-12
- Last Posted Date
- 2025-04-23
- Lead Sponsor
- Evommune, Inc.
- Target Recruit Count
- 160
- Registration Number
- NCT06873516
- Locations
- ๐บ๐ธ
Cahaba Dermatology Skin Health Center, Birmingham, Alabama, United States
๐บ๐ธVelocity Clinical Research, Mobile, Mobile, Alabama, United States
๐บ๐ธCenter for Dermatology Clinical Research, Fremont, California, United States
Efficacy Study of EVO301 in Moderate to Severe Atopic Dermatitis
- Conditions
- Atopic Dermatitis (AD)EczemaEczema Atopic Dermatitis
- Interventions
- Biological: Placebo
- First Posted Date
- 2024-12-09
- Last Posted Date
- 2025-03-18
- Lead Sponsor
- Evommune, Inc.
- Target Recruit Count
- 60
- Registration Number
- NCT06723405
- Locations
- ๐ฆ๐บ
Cornerstone Dermatology, Coorparoo, Australia
๐ฆ๐บMomentum Clinical Research Darlinghurst, Darlinghurst, Australia
๐ณ๐ฟPacific Clinical Research Network (PCRN) Auckland, Auckland, New Zealand
A Study Evaluating the Safety, Tolerability, and Efficacy of EVO756 in Adults With Chronic Inducible Urticaria
- Conditions
- Chronic Inducible Urticaria
- Interventions
- Drug: Oral EVO756
- First Posted Date
- 2024-09-19
- Last Posted Date
- 2025-04-16
- Lead Sponsor
- Evommune, Inc.
- Target Recruit Count
- 30
- Registration Number
- NCT06603220
- Locations
- ๐บ๐ธ
Cahaba Dermatology & Skin Health Center, LLC, Birmingham, Alabama, United States
๐บ๐ธCalifornia Allergy and Asthma Medical Group, Los Angeles, California, United States
๐บ๐ธIntegrative Skin Science and Research, Sacramento, California, United States
Safety and Efficacy Study of EVO101 Topical Cream in Atopic Dermatitis
- First Posted Date
- 2022-10-14
- Last Posted Date
- 2025-03-05
- Lead Sponsor
- Evommune, Inc.
- Target Recruit Count
- 119
- Registration Number
- NCT05579899
- Locations
- ๐บ๐ธ
California Dermatology & Clinical Research Institute, Encinitas, California, United States
๐บ๐ธDermResearch, Austin, Texas, United States
๐บ๐ธDermatology Consulting Services, PLLC, High Point, North Carolina, United States